Annual Revenue
$1.24 B
+$310.32 M+33.26%
31 December 2023
Summary:
Sarepta Therapeutics annual revenue is currently $1.24 billion, with the most recent change of +$310.32 million (+33.26%) on 31 December 2023. During the last 3 years, it has risen by +$541.45 million (+77.14%). SRPT annual revenue is now at all-time high.SRPT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$467.17 M
+$104.24 M+28.72%
30 September 2024
Summary:
Sarepta Therapeutics quarterly revenue is currently $467.17 million, with the most recent change of +$104.24 million (+28.72%) on 30 September 2024. Over the past year, it has increased by +$70.39 million (+17.74%). SRPT quarterly revenue is now at all-time high.SRPT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$1.64 B
+$135.35 M+8.99%
30 September 2024
Summary:
Sarepta Therapeutics TTM revenue is currently $1.64 billion, with the most recent change of +$135.35 million (+8.99%) on 30 September 2024. Over the past year, it has increased by +$397.01 million (+31.93%). SRPT TTM revenue is now at all-time high.SRPT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +17.7% | +31.9% |
| 3 y3 years | +77.1% | +131.9% | +133.7% |
| 5 y5 years | +226.5% | +366.6% | +330.7% |
SRPT Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +77.1% | at high | +131.9% | at high | +133.7% |
| 5 y | 5 years | at high | +226.5% | at high | +366.6% | at high | +330.7% |
| alltime | all time | at high | >+9999.0% | at high | at high | >+9999.0% |
Sarepta Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $467.17 M(+28.7%) | $1.64 B(+9.0%) |
| June 2024 | - | $362.93 M(-12.2%) | $1.50 B(+7.2%) |
| Mar 2024 | - | $413.46 M(+4.2%) | $1.40 B(+12.9%) |
| Dec 2023 | $1.24 B(+33.3%) | $396.78 M(+19.6%) | $1.24 B(+12.5%) |
| Sept 2023 | - | $331.82 M(+27.0%) | $1.10 B(+10.1%) |
| June 2023 | - | $261.24 M(+3.1%) | $1.00 B(+2.8%) |
| Mar 2023 | - | $253.50 M(-1.9%) | $975.68 M(+4.6%) |
| Dec 2022 | $933.01 M(+32.9%) | $258.43 M(+12.2%) | $933.01 M(+6.5%) |
| Sept 2022 | - | $230.27 M(-1.4%) | $876.05 M(+4.9%) |
| June 2022 | - | $233.49 M(+10.7%) | $835.18 M(+9.1%) |
| Mar 2022 | - | $210.83 M(+4.7%) | $765.79 M(+9.1%) |
| Dec 2021 | $701.89 M(+30.0%) | $201.46 M(+6.4%) | $701.89 M(+8.7%) |
| Sept 2021 | - | $189.41 M(+15.4%) | $645.56 M(+7.6%) |
| June 2021 | - | $164.09 M(+11.7%) | $600.08 M(+4.7%) |
| Mar 2021 | - | $146.93 M(+1.2%) | $573.36 M(+6.2%) |
| Dec 2020 | $540.10 M(+41.8%) | $145.14 M(+0.8%) | $540.10 M(+9.1%) |
| Sept 2020 | - | $143.92 M(+4.8%) | $495.07 M(+10.0%) |
| June 2020 | - | $137.36 M(+20.8%) | $450.19 M(+10.5%) |
| Mar 2020 | - | $113.67 M(+13.5%) | $407.50 M(+7.0%) |
| Dec 2019 | $380.83 M(+26.5%) | $100.11 M(+1.1%) | $380.83 M(+4.3%) |
| Sept 2019 | - | $99.04 M(+4.6%) | $365.13 M(+6.0%) |
| June 2019 | - | $94.67 M(+8.8%) | $344.58 M(+6.5%) |
| Mar 2019 | - | $87.01 M(+3.1%) | $323.44 M(+7.4%) |
| Dec 2018 | $301.03 M(+94.7%) | $84.42 M(+7.6%) | $301.03 M(+9.9%) |
| Sept 2018 | - | $78.49 M(+6.7%) | $273.90 M(+13.5%) |
| June 2018 | - | $73.53 M(+13.8%) | $241.36 M(+19.0%) |
| Mar 2018 | - | $64.60 M(+12.8%) | $202.85 M(+31.2%) |
| Dec 2017 | $154.58 M(+2751.6%) | $57.28 M(+24.6%) | $154.58 M(+50.5%) |
| Sept 2017 | - | $45.95 M(+31.3%) | $102.73 M(+80.9%) |
| June 2017 | - | $35.01 M(+114.2%) | $56.77 M(+160.9%) |
| Mar 2017 | - | $16.34 M(+201.5%) | $21.76 M(+301.5%) |
| Dec 2016 | $5.42 M(+332.6%) | $5.42 M(+332.6%) | $5.42 M(+332.6%) |
| Dec 2015 | $1.25 M(-87.2%) | $1.25 M(+4540.7%) | $1.25 M(-87.2%) |
| Dec 2014 | $9.76 M(-31.4%) | $27.00 K(-97.5%) | $9.76 M(-21.0%) |
| Sept 2014 | - | $1.06 M(-59.0%) | $12.36 M(-20.1%) |
| June 2014 | - | $2.58 M(-57.6%) | $15.46 M(-2.3%) |
| Mar 2014 | - | $6.09 M(+131.8%) | $15.83 M(+11.4%) |
| Dec 2013 | $14.22 M(-61.9%) | $2.63 M(-37.0%) | $14.22 M(-24.9%) |
| Sept 2013 | - | $4.17 M(+41.2%) | $18.93 M(-15.2%) |
| June 2013 | - | $2.95 M(-34.0%) | $22.34 M(-27.0%) |
| Mar 2013 | - | $4.47 M(-39.0%) | $30.59 M(-18.1%) |
| Dec 2012 | $37.33 M(-20.6%) | $7.34 M(-3.1%) | $37.33 M(-14.3%) |
| Sept 2012 | - | $7.57 M(-32.4%) | $43.58 M(+0.1%) |
| June 2012 | - | $11.21 M(-0.0%) | $43.53 M(-0.9%) |
| Mar 2012 | - | $11.21 M(-17.5%) | $43.91 M(-6.6%) |
| Dec 2011 | $46.99 M(+59.7%) | $13.59 M(+80.6%) | $46.99 M(-3.9%) |
| Sept 2011 | - | $7.52 M(-35.1%) | $48.92 M(-2.4%) |
| June 2011 | - | $11.59 M(-19.0%) | $50.10 M(+17.8%) |
| Mar 2011 | - | $14.30 M(-7.9%) | $42.51 M(+44.5%) |
| Dec 2010 | $29.42 M(+67.3%) | $15.52 M(+78.3%) | $29.42 M(+54.5%) |
| Sept 2010 | - | $8.70 M(+117.7%) | $19.04 M(+14.1%) |
| June 2010 | - | $4.00 M(+231.7%) | $16.69 M(+6.7%) |
| Mar 2010 | - | $1.21 M(-76.5%) | $15.64 M(-11.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $17.59 M(-17.3%) | $5.14 M(-19.1%) | $17.59 M(-1.9%) |
| Sept 2009 | - | $6.35 M(+115.7%) | $17.93 M(+7.1%) |
| June 2009 | - | $2.94 M(-6.5%) | $16.75 M(-10.8%) |
| Mar 2009 | - | $3.15 M(-42.5%) | $18.78 M(-11.6%) |
| Dec 2008 | $21.26 M(+93.5%) | $5.48 M(+6.0%) | $21.26 M(+1.4%) |
| Sept 2008 | - | $5.17 M(+3.8%) | $20.96 M(+12.1%) |
| June 2008 | - | $4.98 M(-11.4%) | $18.71 M(+16.4%) |
| Mar 2008 | - | $5.63 M(+8.5%) | $16.07 M(+46.3%) |
| Dec 2007 | $10.99 M(+9427.5%) | $5.19 M(+78.1%) | $10.99 M(+88.9%) |
| Sept 2007 | - | $2.91 M(+23.8%) | $5.82 M(+99.3%) |
| June 2007 | - | $2.35 M(+338.7%) | $2.92 M(+398.5%) |
| Mar 2007 | - | $536.00 K(+2962.9%) | $585.40 K(+407.3%) |
| Dec 2006 | $115.30 K(-97.6%) | $17.50 K(+31.6%) | $115.40 K(-92.4%) |
| Sept 2006 | - | $13.30 K(-28.5%) | $1.52 M(-68.3%) |
| June 2006 | - | $18.60 K(-71.8%) | $4.78 M(-0.4%) |
| Mar 2006 | - | $66.00 K(-95.3%) | $4.80 M(+0.4%) |
| Dec 2005 | $4.78 M(+1011.2%) | $1.42 M(-56.8%) | $4.78 M(+31.0%) |
| Sept 2005 | - | $3.28 M(+8250.6%) | $3.65 M(+862.8%) |
| June 2005 | - | $39.30 K(-13.1%) | $379.30 K(+0.8%) |
| Mar 2005 | - | $45.20 K(-84.2%) | $376.30 K(-12.6%) |
| Dec 2004 | $430.50 K(-55.6%) | $285.60 K(+3004.3%) | $430.60 K(+53.7%) |
| Sept 2004 | - | $9200.00(-74.7%) | $280.20 K(-59.1%) |
| June 2004 | - | $36.30 K(-63.5%) | $685.40 K(-15.5%) |
| Mar 2004 | - | $99.50 K(-26.4%) | $811.50 K(-16.3%) |
| Dec 2003 | $969.90 K(+15.9%) | $135.20 K(-67.4%) | $969.90 K(-3.4%) |
| Sept 2003 | - | $414.40 K(+155.2%) | $1.00 M(+22.2%) |
| June 2003 | - | $162.40 K(-37.0%) | $821.70 K(-4.1%) |
| Mar 2003 | - | $257.90 K(+52.4%) | $857.00 K(+2.4%) |
| Dec 2002 | $836.80 K(+18.5%) | $169.20 K(-27.1%) | $836.80 K(-13.1%) |
| Sept 2002 | - | $232.20 K(+17.5%) | $962.90 K(-7.3%) |
| June 2002 | - | $197.70 K(-16.8%) | $1.04 M(+11.9%) |
| Mar 2002 | - | $237.70 K(-19.5%) | $927.80 K(+31.4%) |
| Dec 2001 | $706.10 K(-45.6%) | $295.30 K(-4.0%) | $706.10 K(+62.0%) |
| Sept 2001 | - | $307.50 K(+252.2%) | $435.80 K(+74.0%) |
| June 2001 | - | $87.30 K(+445.6%) | $250.50 K(+38.1%) |
| Mar 2001 | - | $16.00 K(-36.0%) | $181.40 K(-86.0%) |
| Dec 2000 | $1.30 M(+1197.3%) | $25.00 K(-79.5%) | $1.30 M(-5.5%) |
| Sept 2000 | - | $122.20 K(+571.4%) | $1.37 M(+9.8%) |
| June 2000 | - | $18.20 K(-98.4%) | $1.25 M(-6.1%) |
| Mar 2000 | - | $1.13 M(+1031.9%) | $1.33 M(+344.0%) |
| Dec 1999 | $100.00 K(0.0%) | $100.00 K(>+9900.0%) | $300.00 K(+50.0%) |
| Sept 1999 | - | $0.00(-100.0%) | $200.00 K(-33.3%) |
| June 1999 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Mar 1999 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Dec 1998 | $100.00 K(0.0%) | - | - |
| Sept 1998 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| June 1998 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Mar 1998 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Dec 1997 | $100.00 K(0.0%) | - | - |
| Sept 1997 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| June 1997 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Mar 1997 | - | $100.00 K | $100.00 K |
| Dec 1996 | $100.00 K | - | - |
FAQ
- What is Sarepta Therapeutics annual revenue?
- What is the all time high annual revenue for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly revenue year-on-year change?
- What is Sarepta Therapeutics TTM revenue?
- What is the all time high TTM revenue for Sarepta Therapeutics?
- What is Sarepta Therapeutics TTM revenue year-on-year change?
What is Sarepta Therapeutics annual revenue?
The current annual revenue of SRPT is $1.24 B
What is the all time high annual revenue for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual revenue is $1.24 B
What is Sarepta Therapeutics quarterly revenue?
The current quarterly revenue of SRPT is $467.17 M
What is the all time high quarterly revenue for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly revenue is $467.17 M
What is Sarepta Therapeutics quarterly revenue year-on-year change?
Over the past year, SRPT quarterly revenue has changed by +$70.39 M (+17.74%)
What is Sarepta Therapeutics TTM revenue?
The current TTM revenue of SRPT is $1.64 B
What is the all time high TTM revenue for Sarepta Therapeutics?
Sarepta Therapeutics all-time high TTM revenue is $1.64 B
What is Sarepta Therapeutics TTM revenue year-on-year change?
Over the past year, SRPT TTM revenue has changed by +$397.01 M (+31.93%)